The Potential of Natural Products in the Management of COVID-19
Authors:
- 17 September 2024
- book chapter
- Published by Springer Nature
- Vol. 1457, 215-235
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the novel coronavirus that caused a life-threatening viral illness (COVID-19) at the end of 2019. Within a short period of time, this virus spread leading to tremendous loss of life and economic damage. Medications to treat this virus are not yet established, and the process of implementing new strategies for medications is time-consuming. Recent clinical studies revealed the abandonment of the most promising candidates, who later became potential leads. Only through comprehensive study for safety and efficacy the medications, which have already received approval, be repurposed for use in different therapeutic purposes. Natural sources are being used arbitrarily as antiviral drugs and immunity boosters because there are no clear therapies on the horizon. It has long been known that most natural compounds have strong antiviral properties including SARS-CoV-2. Natural remedies have been demonstrated to have inhibitory effects on MERS-CoV and SARS-CoV infections. The non-structural proteins of the virus, such as PLPRO, MPRO, and RdRp, as well as structural proteins like the spike (S) protein, have been demonstrated to have a substantial binding affinity and an inhibitory effect by a variety of natural products, according to in silico research. The virus also demonstrates to be a legitimate target for therapeutic development since it makes use of the host cell's transmembrane ACE2 receptor. In this chapter, we highlight on the potential of alkaloids, phenolic and polyphenolic compounds, flavonoids, terpenoids, cardiac glycosides, and natural products from marine sources against the human coronavirus via different mode of actions. Most of the studied metabolites act either by inhibiting virus replication or by blocking the active site of the protein of the virus either in silico or ex vivo. This review serves as a topic for further study and to discover other secondary metabolites for COVID-19 management.Keywords
This publication has 109 references indexed in Scilit:
- The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-α in mouse adipocytesBiochemical and Biophysical Research Communications, 2010
- Relative and Absolute Stereochemistry of Quinadoline B, an Inhibitor of Lipid Droplet Synthesis in MacrophagesOrganic Letters, 2008
- Pharmacological and therapeutic effects ofBerberis vulgarisand its active constituent, berberinePhytotherapy Research, 2008
- Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome CoronavirusJournal of Medicinal Chemistry, 2007
- ANTIVIRAL EFFECTS OF SAIKOSAPONINS ON HUMAN CORONAVIRUS 229E IN VITROClinical and Experimental Pharmacology and Physiology, 2006
- Identification of natural compounds with antiviral activities against SARS-associated coronavirusAntiviral Research, 2005
- Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophyllaFitoterapia, 2003
- 10‘-Hydroxyusambarensine, a New Antimalarial Bisindole Alkaloid from the Roots of Strychnos usambarensisJournal of Natural Products, 1999
- Chemical Constituents ofIsatis indigoticaPlanta Medica, 1997
- Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivoresPhytochemistry, 1997